Preinjury administration of the calpain inhibitor MDL-28170 attenuates traumatically induced axonal injury

Journal of Neurotrauma

Volumn 20, Issue 3, 2003, Pages 261-268

  Buki, A ^a   Farkas, O ^a   Doczi, T ^a   Povlishock, J T ^b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Axonal injury; Calpain; MDL 28170; Spectrin; Traumatic brain injury

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CALPAIN; [1 [(1 FORMYL 2 PHENYLETHYL)CARBAMOYL] 2 METHYLPROPYL]CARBAMIC ACID BENZYL ESTER;

ACTIN FILAMENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; BOLUS INJECTION; BRAIN CONTUSION; BRAIN INJURY; BRAIN STEM; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOSKELETON; DRUG MECHANISM; IMMUNOHISTOCHEMISTRY; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; RAT; STATISTICAL ANALYSIS; TAIL;

EID: 0037350196     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/089771503321532842     Document Type: Article

References (43)

1. ADAMS, H., MITCHELL, D.E., GRAHAM, D.I., et al. (1977). Diffuse brain damage of immediate impact type. Its relationship to "primary brain-stem damage" in head injury. Brain 100, 489-502.
2. ADAMS, J.H., GRAHAM, D.I., SCOTT, G., et al. (1980). Brain damage in fatal non-missile head injury. J. Clin. Pathol. 33, 1132-1145.
3. BANIK, N.L., SHIELDS, D.C., RAY, S., et al. (1998). Role of calpain in spinal cord injury: effects of calpain and free radical inhibitors. Ann. N.Y. Acad. Sci. 844, 131-7.
4. BARTUS, R.T., HAYWARD, N.J., ELLIOTT, P.J., et al. (1994). Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of postocclusion intra-arterial administration. Stroke 25, 2265-2270.
5. BLUMBERGS, P.C., JONES, N.R., and NORTH, J.B. (1989). Diffuse axonal injury in head trauma. J. Neurol. Neurosurg. Psychiatry 52, 838-841.
6. BUKI, A., KOIZUMI, H., and POVLISHOCK, J.T. (1999b). Moderate posttraumatic hypothermia decreases early calpainmediated proteolysis and concomitant cytoskeletal compromise in traumatic axonal injury. Exp. Neurol. 159, 319-328.
7. BUKI, A., OKONKWO, D.O., and POVLISHOCK, J.T. (1999c). Postinjury cyclosporin A administration limits axonal damage and disconnection in traumatic brain injury. J. Neurotrauma 16, 511-521.
8. BUKI, A., OKONKWO, D.O., WANG, K.K., et al. (2000). Cytochrome c release and caspase activation in traumatic axonal injury. J. Neurosci. 20, 2825-2834.
9. BUKI, A., SIMAN, R., TROJANOWSKI, J.Q., et al. (1999a). The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury. J. Neuropathol. Exp. Neurol. 58, 365-375.
10. FODA, M.A., and MARMAROU, A. (1994). A new model of diffuse brain injury in rats. Part II: Morphological characterization. J. Neurosurg. 80, 301-313.
11. GENNARELLI, T.A., THIBAULT, L.E., ADAMS, J.H., et al. (1982). Diffuse axonal injury and traumatic coma in the primate. Ann. Neurol. 12, 564-574.
12. GENTLEMAN, S.M., NASH, M.J., SWEETING, C.J., et al. (1993). Beta-amyloid precursor protein (beta-APP) as a marker for axonal injury after head injury. Neurosci. Lett. 160, 139-144.
13. HONG, S.C., GOTO, Y., LANZINO, G., et al. (1994). Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia. Stroke 25, 663-669.
14. KAMPFL, A., POSMANTUR, R.M., ZHAO, X., et al. (1997). Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: implications for pathology and therapy: a review and update. J. Neurotrauma 14, 121-134.
15. KOIZUMI, H., and POVLISHOCK, J.T. (1998). Posttraumatic hypothermia in the treatment of axonal damage in an animal model of traumatic axonal injury. J. Neurosurg. 89, 303-309.
16. LEE, K.S., YANAMOTO, H., FERGUS, A., et al. (1997). Calcium-activated proteolysis as a therapeutic target in cerebrovascular disease. Ann. N.Y. Acad. Sci. 825, 95-103.
17. LEE, V.M., CARDEN, M.J., SCHLAEPFER, W.W., et al. (1987). Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats. J. Neurosci. 7, 3474-3488.
18. MARKGRAF, C.G., VELAYO, N.L., JOHNSON, M.P., et al. (1998). Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats. Stroke 29, 152-158.
19. MARMAROU, A., FODA, M.A., VAN DEN BRINK, W., et al. (1994). A new model of diffuse brain injury in rats. Part I: Pathophysiology and biomechanics. J. Neurosurg. 80, 291-300.
20. MAXWELL, W.L., POVLISHOCK, J.T., and GRAHAM, D.L. (1997). A mechanistic analysis of nondisruptive axonal injury: a review. J. Neurotrauma 14, 419-440.
21. McCRACKEN, E., HUNTER, A.J., PATEL, S., et al. (1999). Calpain activation and cytoskeletal protein breakdown in the corpus callosum of head-injured patients. J. Neurotrauma 16, 749-761.
22. MEANEY, D. F., MARGULIES, S.S., and SMITH, D. H. (2000). Diffuse axonal injury. J. Neurosurg. 95, 1108-1110.
23. OKONKWO, D.O., BUKI, A., SIMAN, R., et al. (1999). Cyclosporin A limits calcium-induced axonal damage following traumatic brain injury. Neuroreport 10, 353-358.
24. OKONKWO, D.O., PETTUS, E.H., MOROI, J., et al. (1998). Alteration of the neurofilament sidearm and its relation to neurofilament compaction occurring with traumatic axonal injury. Brain Res. 784, 1-6.
25. OKONKWO, D.O., and POVLISHOCK, J.T. (1999). An intrathecal bolus of cyclosporin A before injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic brain injury. J. Cereb. Blood Flow Metab. 19, 443-451.
26. PETTUS, E.H., CHRISTMAN, C.W., GIEBEL, M.L., et al. (1994). Traumatically induced altered membrane permeability: its relationship to traumatically induced reactive axonal change. J. Neurotrauma 11, 507-522.
27. PETTUS, E.H., and POVLISHOCK, J.T. (1996). Characterization of a distinct set of intra-axonal ultrastructural changes associated with traumatically induced alteration in axolemmal permeability. Brain Res. 722, 1-11.
28. PIKE, B.R., FLINT, J., DUTTA, S., et al. (2001). Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats. J. Neurochem. 78, 1297-1306.
29. PIKE, B.R., ZHAO, X., NEWCOMB, J.K., et al. (1998). Regional calpain and caspase-3 proteolysis of alpha-spectrin after traumatic brain injury. Neuroreport 9, 2437-2442.
30. POSMANTUR, R., KAMPFL, A., SIMAN, R., et al. (1997). A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat. Neuroscience 77, 875-88.
31. POVLISHOCK, J.T. (1992). Traumatically induced axonal injury: pathogenesis and pathobiological implications. Brain Pathol. 2, 1-12.
32. POVLISHOCK, J.T., BECKER, D.P., CHENG, C.L., et al. (1983). Axonal change in minor head injury. J. Neuropathol. Exp. Neurol. 42, 225-242.
33. POVLISHOCK, J.T., ERB, D.E., and ASTRUC, J. (1992). Axonal response to traumatic brain injury: reactive axonal change, deafferentation, and neuroplasticity. J. Neurotrauma 9, S189-S200.
34. POVLISHOCK, J.T., MARMAROU, A., McINTOSH, T., et al. (1997). Impact acceleration injury in the rat: evidence for focal axolemmal change and related neurofilament sidearm alteration. J. Neuropathol. Exp. Neurol. 56, 347-359.
35. SAATMAN, K.E., BOZYCZKO-COYNE, D., MARCY, V., et al. (1996b). Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J. Neuropathol. Exp. Neurol. 55, 850-860.
36. SAATMAN, K.E., MURAI, H., BARTUS, R.T., et al. (1996a). Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat. Proc. Natl. Acad. Sci. U.S.A. 93, 3428-3433.
37. SAATMAN, K.E., ZHANG, C., BARTUS, R.T., et al. (2000). Behavioral efficacy of posttraumatic calpain inhibition is not accompanied by reduced spectrin proteolysis, cortical lesion, or apoptosis. J. Cereb. Blood Flow Metab. 20, 66-73.
38. SHERRIFF, F.E., BRIDGES, L.R., GENTLEMAN, S.M., et al. (1994). Markers of axonal injury in post mortem human brain. Acta Neuropathol. (Berl.) 88, 433-439.
39. STONE, J.R., SINGLETON, R.H., and POVLISHOCK, J.T. (2000). Antibodies to the C-terminus of the beta-amyloid precursor protein (APP): a site specific marker for the detection of traumatic axonal injury. Brain Res. 871, 288-302.
40. STONE, J.R., SINGLETON, R.H., and POVLISHOCK, J.T. (2001). Intra-axonal neurofilament compaction does not evoke local axonal swelling in all traumatically injured axons. Exp. Neurol. 172, 320-331.
41. STONE, J.R., WALKER, S.A., and POVLISHOCK, J.T. (1999). The visualization of a new class of traumatically injured axons through the use of a modified method of microwave antigen retrieval. Acta Neuropathol. (Berl.) 97, 335-345.
42. STRICH, S.J. (1956). Diffuse degeneration of the cerebral white matter in severe dementia following head injury. J. Neurol. Neurosurg. Psychiatry 19, 163-185.
43. WOLF, J.A., STYS, P. K., LUSARDI T., et al. (2001). Traumatic Axonal Injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels. J. Neurosci. 21, 1923-1930.